Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 up-regulation and mTOR activation
Several long noncoding RNAs (lncRNA) are abrogated in cancer but their precise contributions to oncogenesis are still emerging. Here we report that the lncRNA MALAT1 is upregulated in hepatocellular carcinoma (HCC) and acts as a proto-oncogene through Wnt pathway activation and induction of the onco...
Gespeichert in:
| Veröffentlicht in: | Cancer research (Chicago, Ill.) Ill.), 2016-12, Vol.77 (5), p.1155-1167 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1167 |
|---|---|
| container_issue | 5 |
| container_start_page | 1155 |
| container_title | Cancer research (Chicago, Ill.) |
| container_volume | 77 |
| creator | Malakar, Pushkar Shilo, Asaf Mogilevsky, Adi Stein, Ilan Pikarsky, Eli Nevo, Yuval Benyamini, Hadar Elgavish, Sharona Zong, Xinying Prasanth, Kannanganattu V. Karni, Rotem |
| description | Several long noncoding RNAs (lncRNA) are abrogated in cancer but their precise contributions to oncogenesis are still emerging. Here we report that the lncRNA MALAT1 is upregulated in hepatocellular carcinoma (HCC) and acts as a proto-oncogene through Wnt pathway activation and induction of the oncogenic splicing factor SRSF1. Induction of SRSF1 by MALAT1 modulates SRSF1 splicing targets, enhancing the production of anti-apoptotic splicing isoforms and activating the mTOR pathway by modulating the alternative splicing of S6K1. Inhibition of SRSF1 expression or mTOR activity abolishes the oncogenic properties of MALAT1, suggesting that SRSF1 induction and mTOR activation are essential for MALAT1 induced transformation. Our results reveal a mechanism by which lncRNA MALAT1 acts as a proto-oncogene in HCC, modulating oncogenic alternative splicing through SRSF1 upregulation. |
| doi_str_mv | 10.1158/0008-5472.CAN-16-1508 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5334181</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_5334181</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_53341813</originalsourceid><addsrcrecordid>eNqljFtLwzAYhoMorh5-gvD9gcx8a2OzG6EMhxdzQtf7kqWxi-RQ0gPs31tEBK-9ek8PLyEPyJaIXDwyxgTlWb5aboo9xSeKnIkLkiBPBc2zjF-S5JdZkJu-_5wjR8avyWKVr9epQJGQuAu-BR-8Co2ZXbkv4K3YFRVCF4MLg-7hpDs5BKWtHa2MoGRUxgcnodGTtqFz2g9wPMOhPGwRxo5G3c7kYIIH6Rtw1XsJUg1m-u7uyNWHtL2-_9Fb8rx9qTavtBuPTjdqfovS1l00TsZzHaSp_y7enOo2TDVP0wwFpv8--AJDGWrg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 up-regulation and mTOR activation</title><source>American Association for Cancer Research</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Malakar, Pushkar ; Shilo, Asaf ; Mogilevsky, Adi ; Stein, Ilan ; Pikarsky, Eli ; Nevo, Yuval ; Benyamini, Hadar ; Elgavish, Sharona ; Zong, Xinying ; Prasanth, Kannanganattu V. ; Karni, Rotem</creator><creatorcontrib>Malakar, Pushkar ; Shilo, Asaf ; Mogilevsky, Adi ; Stein, Ilan ; Pikarsky, Eli ; Nevo, Yuval ; Benyamini, Hadar ; Elgavish, Sharona ; Zong, Xinying ; Prasanth, Kannanganattu V. ; Karni, Rotem</creatorcontrib><description>Several long noncoding RNAs (lncRNA) are abrogated in cancer but their precise contributions to oncogenesis are still emerging. Here we report that the lncRNA MALAT1 is upregulated in hepatocellular carcinoma (HCC) and acts as a proto-oncogene through Wnt pathway activation and induction of the oncogenic splicing factor SRSF1. Induction of SRSF1 by MALAT1 modulates SRSF1 splicing targets, enhancing the production of anti-apoptotic splicing isoforms and activating the mTOR pathway by modulating the alternative splicing of S6K1. Inhibition of SRSF1 expression or mTOR activity abolishes the oncogenic properties of MALAT1, suggesting that SRSF1 induction and mTOR activation are essential for MALAT1 induced transformation. Our results reveal a mechanism by which lncRNA MALAT1 acts as a proto-oncogene in HCC, modulating oncogenic alternative splicing through SRSF1 upregulation.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-16-1508</identifier><identifier>PMID: 27993818</identifier><language>eng</language><ispartof>Cancer research (Chicago, Ill.), 2016-12, Vol.77 (5), p.1155-1167</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids></links><search><creatorcontrib>Malakar, Pushkar</creatorcontrib><creatorcontrib>Shilo, Asaf</creatorcontrib><creatorcontrib>Mogilevsky, Adi</creatorcontrib><creatorcontrib>Stein, Ilan</creatorcontrib><creatorcontrib>Pikarsky, Eli</creatorcontrib><creatorcontrib>Nevo, Yuval</creatorcontrib><creatorcontrib>Benyamini, Hadar</creatorcontrib><creatorcontrib>Elgavish, Sharona</creatorcontrib><creatorcontrib>Zong, Xinying</creatorcontrib><creatorcontrib>Prasanth, Kannanganattu V.</creatorcontrib><creatorcontrib>Karni, Rotem</creatorcontrib><title>Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 up-regulation and mTOR activation</title><title>Cancer research (Chicago, Ill.)</title><description>Several long noncoding RNAs (lncRNA) are abrogated in cancer but their precise contributions to oncogenesis are still emerging. Here we report that the lncRNA MALAT1 is upregulated in hepatocellular carcinoma (HCC) and acts as a proto-oncogene through Wnt pathway activation and induction of the oncogenic splicing factor SRSF1. Induction of SRSF1 by MALAT1 modulates SRSF1 splicing targets, enhancing the production of anti-apoptotic splicing isoforms and activating the mTOR pathway by modulating the alternative splicing of S6K1. Inhibition of SRSF1 expression or mTOR activity abolishes the oncogenic properties of MALAT1, suggesting that SRSF1 induction and mTOR activation are essential for MALAT1 induced transformation. Our results reveal a mechanism by which lncRNA MALAT1 acts as a proto-oncogene in HCC, modulating oncogenic alternative splicing through SRSF1 upregulation.</description><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqljFtLwzAYhoMorh5-gvD9gcx8a2OzG6EMhxdzQtf7kqWxi-RQ0gPs31tEBK-9ek8PLyEPyJaIXDwyxgTlWb5aboo9xSeKnIkLkiBPBc2zjF-S5JdZkJu-_5wjR8avyWKVr9epQJGQuAu-BR-8Co2ZXbkv4K3YFRVCF4MLg-7hpDs5BKWtHa2MoGRUxgcnodGTtqFz2g9wPMOhPGwRxo5G3c7kYIIH6Rtw1XsJUg1m-u7uyNWHtL2-_9Fb8rx9qTavtBuPTjdqfovS1l00TsZzHaSp_y7enOo2TDVP0wwFpv8--AJDGWrg</recordid><startdate>20161219</startdate><enddate>20161219</enddate><creator>Malakar, Pushkar</creator><creator>Shilo, Asaf</creator><creator>Mogilevsky, Adi</creator><creator>Stein, Ilan</creator><creator>Pikarsky, Eli</creator><creator>Nevo, Yuval</creator><creator>Benyamini, Hadar</creator><creator>Elgavish, Sharona</creator><creator>Zong, Xinying</creator><creator>Prasanth, Kannanganattu V.</creator><creator>Karni, Rotem</creator><scope>5PM</scope></search><sort><creationdate>20161219</creationdate><title>Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 up-regulation and mTOR activation</title><author>Malakar, Pushkar ; Shilo, Asaf ; Mogilevsky, Adi ; Stein, Ilan ; Pikarsky, Eli ; Nevo, Yuval ; Benyamini, Hadar ; Elgavish, Sharona ; Zong, Xinying ; Prasanth, Kannanganattu V. ; Karni, Rotem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_53341813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Malakar, Pushkar</creatorcontrib><creatorcontrib>Shilo, Asaf</creatorcontrib><creatorcontrib>Mogilevsky, Adi</creatorcontrib><creatorcontrib>Stein, Ilan</creatorcontrib><creatorcontrib>Pikarsky, Eli</creatorcontrib><creatorcontrib>Nevo, Yuval</creatorcontrib><creatorcontrib>Benyamini, Hadar</creatorcontrib><creatorcontrib>Elgavish, Sharona</creatorcontrib><creatorcontrib>Zong, Xinying</creatorcontrib><creatorcontrib>Prasanth, Kannanganattu V.</creatorcontrib><creatorcontrib>Karni, Rotem</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malakar, Pushkar</au><au>Shilo, Asaf</au><au>Mogilevsky, Adi</au><au>Stein, Ilan</au><au>Pikarsky, Eli</au><au>Nevo, Yuval</au><au>Benyamini, Hadar</au><au>Elgavish, Sharona</au><au>Zong, Xinying</au><au>Prasanth, Kannanganattu V.</au><au>Karni, Rotem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 up-regulation and mTOR activation</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><date>2016-12-19</date><risdate>2016</risdate><volume>77</volume><issue>5</issue><spage>1155</spage><epage>1167</epage><pages>1155-1167</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><abstract>Several long noncoding RNAs (lncRNA) are abrogated in cancer but their precise contributions to oncogenesis are still emerging. Here we report that the lncRNA MALAT1 is upregulated in hepatocellular carcinoma (HCC) and acts as a proto-oncogene through Wnt pathway activation and induction of the oncogenic splicing factor SRSF1. Induction of SRSF1 by MALAT1 modulates SRSF1 splicing targets, enhancing the production of anti-apoptotic splicing isoforms and activating the mTOR pathway by modulating the alternative splicing of S6K1. Inhibition of SRSF1 expression or mTOR activity abolishes the oncogenic properties of MALAT1, suggesting that SRSF1 induction and mTOR activation are essential for MALAT1 induced transformation. Our results reveal a mechanism by which lncRNA MALAT1 acts as a proto-oncogene in HCC, modulating oncogenic alternative splicing through SRSF1 upregulation.</abstract><pmid>27993818</pmid><doi>10.1158/0008-5472.CAN-16-1508</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-5472 |
| ispartof | Cancer research (Chicago, Ill.), 2016-12, Vol.77 (5), p.1155-1167 |
| issn | 0008-5472 1538-7445 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5334181 |
| source | American Association for Cancer Research; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| title | Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 up-regulation and mTOR activation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T04%3A41%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long%20noncoding%20RNA%20MALAT1%20promotes%20hepatocellular%20carcinoma%20development%20by%20SRSF1%20up-regulation%20and%20mTOR%20activation&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=Malakar,%20Pushkar&rft.date=2016-12-19&rft.volume=77&rft.issue=5&rft.spage=1155&rft.epage=1167&rft.pages=1155-1167&rft.issn=0008-5472&rft.eissn=1538-7445&rft_id=info:doi/10.1158/0008-5472.CAN-16-1508&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_5334181%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/27993818&rfr_iscdi=true |